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Abstract
Background: Peritoneal dissemination of ovarian tumors is a major prognostic parameter in ovarian malignancies.
Analysis of peritoneal washing cytology serves as a useful predictor of ovarian surface involvement and peritoneal
metastasis even in the absence of clinical omental spread. The aim of the current study is to correlate peritoneal
cytology with various histologic features of ovarian cancers in our setup.
Methods: A total of 60 cases of ovarian tumors were included in the study that underwent total abdominal
hysterectomy with bilateral salpingo-oophorectomy and omental and lymph node sampling during 2009 till 2014
at the Liaquat National Hospital, Karachi. Any free abdominal fluid was aspirated at the time of surgery. In the
absence of free fluid, peritoneal washing was done with 50–100 ml of normal saline. Four cytospin preparations
were done along with a cell block preparation. Correlation of peritoneal cytology with various histologic parameters
was performed.
Results: Out of the 60 cases of ovarian tumors involved in the study, 56 were surface epithelial tumors, 2 germ cell
tumors, and 2 metastatic carcinomas. The mean tumor size was 9.6 cm. Capsular invasion was seen in 61 % of the
cases, and omental metastasis in 51 % of the cases. Serous carcinoma was found to have a significantly higher
frequency of positive peritoneal cytology (76.9 %) compared to endometrioid and mucinous carcinomas (44 and
25 %, respectively). A significant positive correlation was seen between positive peritoneal cytology and capsular
invasion and omental metastasis with a p value of <0.001.
Conclusions: Positive peritoneal washing cytology has been implemented in ovarian cancer guidelines because of
its prognostic significance in ovarian tumors. In addition to being an indicator of peritoneal metastasis, positive
cytology also correlates with capsular invasion and histologic type in ovarian tumors. Therefore, it should always be
used as an adjunctive tool in the surgical management of ovarian tumors.
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Background
Ovarian cancer is a significant cause of morbidity and
mortality in women in this part of the world due to lack
of any effective screening protocol. According to Karachi
cancer registry, ovarian cancer represents the third most
common malignancy in Karachi with serous adenocar-
cinoma being the most common (33.3 %) [1]. Ovarian
cancers are usually detected late in the disease course
when it is significantly enlarged in size to cause abdom-
inal distention and distress. However, despite of being of
large sizes, ovarian tumors may still be confined to the
ovaries. On the other hand, omental and peritoneal
spread of ovarian cancers has a huge impact on progno-
sis and upstages prognostic morbidity. Analysis of peri-
toneal washing cytology (PWC) serves as a useful
predictor of ovarian surface involvement and peritoneal
metastasis in ovarian cancers [2, 3]. It can also detect
subclinical peritoneal spread of the disease. While the
procedure is routinely done in our institution as part of
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the protocol for all surgeries of suspected ovarian malig-
nancies, its usefulness has not been objectively evalu-
ated. The aim of the current study is to correlate
peritoneal cytology with various histologic features of
ovarian malignancies.
Methods
The study was approved by the Liaquat National Hos-
pital and Medical College ethical review committee, and
written informed consent was obtained from all subjects.
A total of 60 cases of borderline and malignant ovarian
tumors were included in the study that underwent total
abdominal hysterectomy and bilateral salpingo-
oophorectomy (TAH with BSO) along with omental and
lymph node samplings at the Liaquat National Hospital,
Karachi from January 2009 till December 2014. After
opening the abdominal cavity, any free fluid was aspi-
rated. Various areas of peritoneal cavity including para-
colic gutters were lavaged with 50–100 ml of normal
saline and sent for cytologic examination. Four cytospin
preparations were stained with hematoxylin and eosin
and Papanicolaou stains after fixation along with a cell
block preparation. TAH with BSO was performed after-
wards with omental and lymph node samplings. All
cases undergoing ovarian surgery with peritoneal cyto-
logic examination, omental and lymph node samplings
were consecutively enrolled in the study. Pathologists
reporting peritoneal cytology were blinded with the sur-
gical pathology findings. Results of peritoneal cytology
were correlated with various histologic features of ovarian
tumors including histologic type, grade, tumor size, capsu-
lar invasion, and omental metastasis (Figs. 1 and 2), using
chi-square test (univariate analysis). A p value of <0.05
was considered as statistically significant.
Results
The mean age at diagnosis was 49.9 years (±14.8). Out
of the 60 cases of ovarian tumors involved in the study,
56 were surface epithelial tumors, 2 germ cell tumors,
and 2 metastatic carcinomas. The mean tumor size was
11.2 cm. Capsular invasion was seen in 61 % of tumors
and omental metastasis in 51 % of tumors. Table 1
shows the histopathologic features of ovarian tumors in-
volved in the study. Serous tumors were the most fre-
quent histologic subtype followed by mucinous and
endometrioid tumors. Serous carcinoma had a signifi-
cantly higher frequency of positive peritoneal cytology
(76.9 %) compared to endometrioid and mucinous carcin-
omas (44 and 25 %, respectively) as shown in Table 2. A
significant positive correlation was seen between positive
peritoneal cytology with omental metastasis and capsular
invasion with a p value of <0.001 (Tables 3 and 4). Higher
grade tumors were more likely to have positive peritoneal
cytology than low-grade tumors; however, the p value was
not found to be statistically significant (Table 5). Tumors
of smaller sizes tend to have a significantly higher inci-
dence of positive peritoneal cytology (Table 6).
Discussion
Peritoneal washing cytology is a useful indicator of ovar-
ian surface involvement and peritoneal dissemination by
ovarian tumors. It may identify subclinical peritoneal
spread and thus provide valuable staging and prognostic
information [4]. For the same reason, PWC was imple-
mented in ovarian cancer guidelines and is routinely per-
formed in ovarian cancer surgeries.
In our study, we report our experience of PWC with
emphasis over its correlation with histological parame-
ters, i.e., tumor type, tumor grade, tumor size, capsular
invasion, and omental metastasis.
Cytology detection rates of abdominal spread in ovarian
cancers vary in different studies. Fadare et al. reported
Fig. 1 Positive peritoneal cytology in ovarian serous carcinoma
Fig. 2 Capsular invasion in ovarian carcinoma
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25 % and Rubin et al. reported 30 % detection rate, while
Colgan et al. revealed 50 % detection rate [5–7]. As much
as 90 % positive cytology detection rate has also been re-
ported in a study [8]. This can be due to the inclusion of
ascitic fluid along with peritoneal washings, as ascitic fluid
has a much higher rate of detecting malignant cells.
In our observation, serous carcinomas (n = 26.79 %)
were most likely and mucinous carcinoma (n = 8, 25 %)
were least likely to involve abdominal cavity as repre-
sented by positive peritoneal cytology. Forty-four percent
of endometrioid carcinoma (n = 9), 100 % of clear cell
carcinoma (n = 1), 100 % of transitional cell carcinoma
(n = 1), 66 % of malignant mullerian tumors (n = 3), and
50 % of germ cell tumors (n = 2) showed positive cy-
tology. Fadare et al. reported 71.4 % of serous carcinoma
(n = 57), 55 % of endometrioid carcinoma (n = 30), 20 %
of clear cell carcinoma (n = 19), and 50 % of mucinous
carcinoma (n = 13) showing positive peritoneal cytology
[5]. Similar study by Rubin et al. analyzed 96 cases of
ovarian tumors of which 29 cases showed positive PWC
[6]. The histological subtypes included the following:
serous, 21 of 66 (32 %); endometrioid, 3 of 11 (27 %);
mucinous 0 of 1 (0 %); and clear cell carcinoma, 2 of 3
(66 %).
In patients with ovarian serous tumor of low malig-
nant potential and borderline tumors, PWC is a
Table 1 Histopathologic features of ovarian tumors and its correlation with peritoneal cytology
Frequency Omental metastasis Capsular invasion Tumor size
Frequency(%) Frequency(%) Frequency(%) Mean
Serous tumors 27 11.8
Malignant 26 20(76.9) 19(73.1) 22(84.6) 8.6
Borderline 1 0(0) 0(0) 0(0) 15
Mucinous tumors 12 22.6
Malignant 8 2(25) 2(25) 2(25) 24.8
Borderline 4 0(0) 0(0) 1(25) 20.5
Clear cell carcinoma 1 1(100) 1(100) 1(100) 7
Transitional cell carcinoma 2 2(100) 2(100) 1(50) 8
Malignant mixed mullerian tumor 3 2(66.7) 1(33.3) 3(100) 9.3
Endometrioid carcinoma 9 4(44.4) 2(22.2) 3(33.3) 6.5
Metastatic carcinoma 2 1(50) 1(50) 1(50) 3.5
Dysgerminoma 2 1(50) 1(50) 1(50) 11
Poorly differentiated adenocarcinoma 2 2(100) 2(100) 2(100) 7
Total 60 35(58.3) 31(51.6) 37(61.6) 9.65
Table 2 Correlation of peritoneal cytology with histological subtype of tumor
Peritoneal.cytology p value
Positive Negative
Frequency % Frequency %
Serous carcinoma 20 76.92 6 23.08 0.042
Endometrioid carcinoma 4 44.44 5 55.56
Mucinous carcinoma 2 25.00 6 75.00
Clear cell carcinoma 1 100.00 0 0.00
Transitional cell carcinoma 2 100.00 0 0.00
Malignant mixed mullerian tumor 2 66.67 1 33.33
Borderline serous tumor 0 0.00 1 100.00
Borderline mucinous tumor 0 0.00 4 100.00
Metastatic carcinoma 1 50.00 1 50.00
Dysgerminoma 1 50.00 1 50.00
Poorly differentiated adenocarcinoma 2 100.00 0 0.00
Total 35 58.33 25 41.67
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relatively sensitive indicator for presence of peritoneal
implants whether invasive or non-invasive [2]. Positive
cytology upstages borderline tumors. Mulvany, in his
study, concluded that the clinical value of PWC lies in
upstaging 63 % of borderline ovarian tumors [3]. Cheng
et al. demonstrated a 44 % positive cytology detection
rate of borderline mucinous tumors [9]. However, in our
study, there were only five borderline tumor cases (one
serous, four mucinous). All showed negative cytology as
well as no omental metastasis.
Omental metastasis/peritoneal histology are used as a
standard to determine the sensitivity and specificity of
PWC. In our study, 35 cases showed positive PWC and
31 showed omental metastasis. There were six cases (6/
35; 17 %) that were cytology positive and histology nega-
tive. These included two serous carcinomas, two endo-
metrioid carcinoma, one mucinous carcinoma, and one
MMT. Out of 25 cytology negative cases, only two
showed omental metastasis (2/25; 8 %), one serous, and
one mucinous. Sneige et al., in their study, observed that
11/70 cases (16 %) were cytology positive and biopsy
negative [2]. In a study by Zuna and Behrens, 112 ovar-
ian carcinoma cases were analyzed, and only three stage
I cases had positive cytology and negative peritoneal
histology (two carcinomas and one borderline tumor)
[10]. Of these, only patients with borderline tumors were
alive at the last follow-up. Other two died of the disease.
In one study, late recurrences were reported in patients
with low-grade serous tumors having negative staging
biopsy, and they concluded that this may be due to sam-
pling error at the site of implant [11]. Hence, stage I dis-
ease without omental metastasis but positive cytology
may indicate increased risk of tumor recurrence, and
this emphasizes the importance of PWC. In our study,
the correlation of PWC with omental metastasis was sta-
tistically significant.
According to the recent Federation of Gynecology and
Obstetrics (FIGO) guidelines, capsular rupture upstages
a stage I tumor to stage IC2 and positive cytology to
stage IC3 [12]. Hence, determination of capsular integ-
rity is important as this changes cancer stage. In our
study, we tried to correlate capsular invasion with PWC.
Out of 60 cases, 37 showed capsular invasion but not all
showed positive cytology. Of cytology-positive cases,
only 5 had capsule intact and out of 25 cytology negative
cases, and 7 had capsular rupture. Of 26 serous carcin-
omas, 22 (84 %) showed capsular invasion while 20
(76.9 %) showed positive cytology. One borderline mu-
cinous tumor had capsular invasion but a negative cy-
tology. All three MMT showed ruptured capsule
(invasion) with two showing positive PWC. Only one
case (endometrioid carcinoma) showed positive cytology
with intact capsule. With or without capsular invasion,
the presence of PWC in stage I disease alone is sufficient
to upgrade the tumor. We observed a strong correlation
between capsular invasion and PWC (p = <0.001).
In our study, the mean tumor size was different for
different tumor types. It was 11.58 cm for serous tu-
mors, 6.5 cm for endometrioid tumors, and 22 cm for
mucinous neoplasms. The largest tumor size was 30 cm
of mucinous carcinoma. Positive peritoneal cytology was
correlated to tumor size, and we observed that most of
the positive cytology cases had tumor size of less than
10 cm (28/35 cases, 84 %) and only one tumor of more
than 20 cm showed positive cytology. Interestingly, most
(7/8) large tumors (>20 cm) had negative cytology. Of
these, only one showed omental metastasis, i.e., histology
positive. The rest had intact capsules and no omental
metastasis. All large tumors were mucinous. The only
large tumor with positive cytology was 30 cm in size
with capsular invasion and omental metastasis. We ob-
served that mucinous tumors may acquire large sizes
but mostly remain organ confined with negative cy-
tology. Some of the intermediate sized serous tumors




Frequency(%) capsular.invasion p value
Present Absent
Positive 35(58.3) 30(85.7) 5(14.3) <0.001
Negative 25(41.6) 7(28.0) 18(72.0)
Total 60 37(61.7) 23(38.3)




Frequency(%) omental.metastasis p value
Present Absent
Positive 35(58.3) 29(82.9) 6(17.1) <0.001
Negative 25(41.6) 2(8.0) 23(92.0)
Total 60 31(51.7) 29(48.3)
Table 5 Correlation of peritoneal cytology with tumor grade
Peritoneal
cytology
Tumor grade Total p value
Low grade High grade Intermediate
Positive 1(20 %) 30(66.6 %) 4(40 %) 35(58.3 %)
Negative 4(80 %) 15(33.3 %) 6(60 %) 25(41.6 %) 0.058
Total 5(8.3 %) 45(75 %) 10(16.6 %) 60
Table 6 Correlation of peritoneal cytology with tumor size
Peritoneal
cytology
Tumor size Total p value
<10 cm 10–20 cm >20 cm
Positive 28(84.8 %) 6(31.5 %) 1(12.5 %) 35(58.3 %)
Negative 5(15.1 %) 13(68.4 %) 7(87.5 %) 25(41.6 %) <0.001
Total 33(55 %) 19(31.6 %) 8(13.3 %) 60
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also showed negative cytology. Hence, smaller tumors
have a significantly more incidence of positive PWC.
Tumor grade also had an impact on abdominal spread
of ovarian tumors. We found out that 30 out of the 35
cytology-positive cases had high histological grade, four
had intermediate grade, and only one had low grade. Fif-
teen (33 %) of high-grade tumors showed negative hist-
ology. Ozkara reported that PW were significantly more
likely to yield malignant cells in higher grade than lower
grade tumors [13].
Conclusions
In conclusion, positive peritoneal washing cytology is a
useful prognostic factor in ovarian tumors. In addition
to being an indicator of peritoneal metastasis, positive
cytology also correlates with capsular invasion, tumor
type, and tumor grade in ovarian tumors.
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